204 related articles for article (PubMed ID: 17994361)
1. Dexamethasone incorporating liposomes: effect of lipid composition on drug trapping efficiency and vesicle stability.
Tsotas VA; Mourtas S; Antimisiaris SG
Drug Deliv; 2007 Oct; 14(7):441-5. PubMed ID: 17994361
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone.
Bhardwaj U; Burgess DJ
Int J Pharm; 2010 Mar; 388(1-2):181-9. PubMed ID: 20079409
[TBL] [Abstract][Full Text] [Related]
3. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide liposomes: encapsulation efficiency and in vitro stability.
Kallinteri P; Fatouros D; Klepetsanis P; Antimisiaris SG
J Liposome Res; 2004; 14(1-2):27-38. PubMed ID: 15461930
[TBL] [Abstract][Full Text] [Related]
5. Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment.
Justo OR; Moraes AM
J Pharm Pharmacol; 2005 Jan; 57(1):23-30. PubMed ID: 15638989
[TBL] [Abstract][Full Text] [Related]
6. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.
Mohammed AR; Weston N; Coombes AG; Fitzgerald M; Perrie Y
Int J Pharm; 2004 Nov; 285(1-2):23-34. PubMed ID: 15488676
[TBL] [Abstract][Full Text] [Related]
7. Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition.
Hatzi P; Mourtas S; Klepetsanis PG; Antimisiaris SG
Int J Pharm; 2007 Mar; 333(1-2):167-76. PubMed ID: 17101248
[TBL] [Abstract][Full Text] [Related]
8. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM
J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629
[TBL] [Abstract][Full Text] [Related]
10. Combined strategies for liposome characterization during in vitro digestion.
Hermida LG; Sabés-Xamaní M; Barnadas-Rodríguez R
J Liposome Res; 2009; 19(3):207-19. PubMed ID: 19548842
[TBL] [Abstract][Full Text] [Related]
11. The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations.
Anderson M; Omri A
Drug Deliv; 2004; 11(1):33-9. PubMed ID: 15168789
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical properties of liposomes incorporating hydrochlorothiazide and chlorothiazide.
Fatouros DG; Antimisiaris SG
J Drug Target; 2001; 9(1):61-74. PubMed ID: 11378524
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical properties and antioxidant activity of gamma-oryzanol-loaded liposome formulations for topical use.
Viriyaroj A; Ngawhirunpat T; Sukma M; Akkaramongkolporn P; Ruktanonchai U; Opanasopit P
Pharm Dev Technol; 2009; 14(6):665-71. PubMed ID: 19883256
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyzine- and cetirizine-loaded liposomes: effect of duration of thin film hydration, freeze-thawing, and changing buffer pH on encapsulation and stability.
Elzainy AA; Gu X; Simons FE; Simons KJ
Drug Dev Ind Pharm; 2005 Mar; 31(3):281-91. PubMed ID: 15830724
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-HMPAO-labeled liposomes: an investigation into the effects of some formulation factors on labeling efficiency and in vitro stability.
Mirahmadi N; Babaei MH; Vali AM; Daha FJ; Kobarfard F; Dadashzadeh S
Nucl Med Biol; 2008 Apr; 35(3):387-92. PubMed ID: 18355695
[TBL] [Abstract][Full Text] [Related]
16. Liposomes for drug delivery to the lungs by nebulization.
Zaru M; Mourtas S; Klepetsanis P; Fadda AM; Antimisiaris SG
Eur J Pharm Biopharm; 2007 Nov; 67(3):655-66. PubMed ID: 17540552
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of multilamellar liposomes containing pyridostigmine.
Souza AC; Grabe-Guimarães A; Souza J; Botacim WE; Almeida TM; Frézard FJ; Silva Barcellos NM
Pharm Dev Technol; 2014 Jun; 19(4):454-9. PubMed ID: 23682846
[TBL] [Abstract][Full Text] [Related]
18. Characterization, stability and in-vivo distribution of asialofetuin glycopeptide incorporating DSPC/CHOL liposomes prepared by mild cholate incubation.
Kallinteri P; Liao WY; Antimisiaris SG; Hwang KH
J Drug Target; 2001 Apr; 9(2):155-68. PubMed ID: 11697109
[TBL] [Abstract][Full Text] [Related]
19. Investigation of factors affecting controlled release from photosensitive DMPC and DSPC liposomes.
Aygun A; Torrey K; Kumar A; Stephenson LD
Appl Biochem Biotechnol; 2012 Jun; 167(4):743-57. PubMed ID: 22592778
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method.
Qiu L; Jing N; Jin Y
Int J Pharm; 2008 Sep; 361(1-2):56-63. PubMed ID: 18573626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
